Global miRNA Market
Sizing, Segmentation, & Growth Forecast (2025-2030)
Last updated: August 2026
Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.
Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).
1. Summary
The Global miRNA Market was valued at $2.0 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 17.5% CAGR, to an estimated market size of $4.6 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.
2. Market Definition
The global miRNA market encompasses the development, production, and commercialization of products (consumables, kits, and instruments) and services (profiling, sequencing, and quantification) focused on microRNA molecules. These short, non-coding RNA molecules are utilized as diagnostic biomarkers, therapeutic targets, and tools for biomarker discovery across oncology, cardiology, and neurology.
3. Trends & Demand Drivers
Several key trends are expected to significantly impact the miRNA Market in the period 2025-30:
- Integration of Artificial Intelligence and machine learning is accelerating miRNA target prediction and the validation of complex disease-specific signatures.
- Rising adoption of liquid biopsies is positioning miRNA as a superior, non-invasive biomarker for early-stage cancer detection and real-time monitoring.
- Increased investment in RNA therapeutics, specifically anti-miR and miR-mimic medicines, is expanding the market beyond research tools into clinical treatment.
- Technological advancements in Next-Generation Sequencing (NGS) and digital PCR are significantly enhancing the sensitivity and throughput of miRNA profiling.
- The shift toward precision medicine is driving the demand for miRNA-based companion diagnostics to personalize treatment pathways for chronic conditions.
- Expansion of multi-omics research approaches is integrating miRNA data with genomics and proteomics to provide a holistic view of disease pathogenesis.
- Growing prevalence of chronic diseases and aging global demographics are fueling the clinical demand for advanced molecular diagnostic solutions.
4. Market Breakdown
The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:
Geographies
- North America
- Europe
- Asia-Pacific
- Rest of World
Segments
- Consumables and Products
- Services
- Instruments